학술논문
101P Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S219-S219
Subject
Language
ISSN
0923-7534